Side population cells from HXO-Rb44 retinoblastoma cell line have cancer-initiating property

International Journal of Ophthalmology

Volumn 4, Issue 5, 2011, Pages 461-465

  She, Jun Jun ^a   Zhang, Peng Ge ^b   Che, Xiang Ming ^a   Wang, Xuan ^a   Wang, Zi Ming ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b XIDIAN UNIVERSITY   (China)

Author keywords

HXO Rb44; Retinoblastoma; Self renewal; Side population

Indexed keywords

EID: 84897594809     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2011.05.01     Document Type: Article

References (17)

1. Al-Hajj M., Wicha MS, Benito-Hernandez A, Morrison S.J., Clarke MF Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983-3988.
2. Singh SK, Hawkins C, Clarke I.D., Squire JA, Bayani J, Hide T, Henkelman R.M., Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature. 2004;432:396-401.
3. Collins A.T., Berry PA, Hyde C, Stower M.J., Maitland N J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65:10946-10951.
4. Ricci-Vitiani L., Lombardi DG, Pilozzi E, Biffoni M., Todaro M, Peschle C, De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445:111-115.
5. Broadley KW, Hunn MK, Farrand K.J., Price KM, Grasso C, Miller RJ, Hermans I.F., McConnell MJ. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Stem Cells. 2011;29(3):452-461.
6. Natarajan K, Xie Y, Nakanishi T., Beck WT, Bauer KS, Ross DD Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine. Biochim Biophys Acta. 2011;1809(7):295-305.
7. Zhao C, You ZP N ew progression in the treatment of retinoblastoma. Int J Ophthalmol(Guoji Yanke Zazhi) 2009;9(1):139-141.
8. Doyle LA, Ross DD Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) Oncogene. 2003;22:7340-7358.
9. Pomp O, Dreesen O, Leong D.F., Meller-Pomp O, Tan TT, Zhou F, Colman A. Unexpected X Chromosome Skewing during Culture and Reprogramming of Human Somatic Cells Can Be Alleviated by Exogenous Telomerase. Cell Stem Cell. 2011;9(2):156-165.
10. Costea DE, Gammon L, Kitajima K., Harper L, Mackenzie IC Epithelial stem cells and malignancy. J Anat. 2008;213(1):45-51.
11. Chumsri S, Phatak P, Edelman M.J., Khakpour N., Hamburger AW, Burger AM Cancer stem cells and individualized therapy. Cancer Genomics Proteomics. 2007;4(3):165-174.
12. Parkins CS, Hill SA, Stratford M.R., Dennis MF, Chaplin DJ Metabolic and clonogenic consequences of ischaemia reperfusion insult in solid tumours. Exp Physiol. 1997;82(2):361-368.
13. Chumsri S, Phatak P, Edelman M.J., Khakpour N., Hamburger AW, Burger A M. Cancer stem cells and individualized therapy. Cancer Gen Pro. 2007;4:165-174.
14. Farnie G, Clarke RB Mammary stem cells and breast cancer-role of Notch signaling. Stem Cell Rev. 2007;3:169-175.
15. She JJ, Zhang PG, Wang Z.M., Gan WM, Che XM Identification of side population cells from bladder cancer cells by DyeCycle Violet staining. Cancer Biol Ther. 2008;7(10):1663-1668.
16. Jiang L, Li J, Song L. stem cells and cancer. Acta Biochim Biophys Sin (Shanghai) 2009;41(7):527-534.
17. Niwa H, Miyazaki J, Smith A G. Quantitative expression of Oct-3/4 defines differentiation. dedifferentiation or self-renewal of ES cells. Nat Genet. 2000;24:372-376.